Thomson Reuters Corporation : Thomson Reuters Helps Pharmaceutical Executives Identify Drugs with Repositioning Potential

Unique approach uses Thomson Reuters drug data and expert analysis to identify repositioning candidates PHILADELPHIA, PA, October 23, 2012 – With more than 2,000 drugs reintroduced for alternative purposes to date, drug repositioning has become …

Share